Features
There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues Tom Cowap of...
Merck KGaA's Chris Round, Head of EMEA Region, spoke with Pharmafile.com to discuss his time at both the US and German firms which bear the name...
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal products available to...
The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the EMA is ensuring that the...
A new report has canvassed the intentions of industry players in the use of real world data and evidence over the coming years. Matt Fellows...
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting its stride, with...
Speaking to Pharmafocus , David Nicholson, Chief R&D Officer at Allergan, revealed that the company has big plans in the migraine space to...
Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support network...
The reaction from the pharmaceutical industry has been mixed since the announcement of serialisation requirements. Ben Hargreaves...
With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences to find out what 2017 meant...
